SMTL ID : 5b4l.2 (1 other biounit)

Crystal structure of the catalytic domain of human PDE10A complexed with 1-(cyclopropylmethyl)-5-(2-(2,3-dihydro-1H-imidazo[1,2-a]benzimidazol-1-yl)ethoxy)-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: D.113, E.141 Ligands: ZN.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.113, H2O.1, H2O.1, H2O.1, H2O.1

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 5 residues within 4Å: Chain A: H.78, H.112, D.113, D.223 Ligands: MG.1 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.78, A:H.112, A:D.113, A:D.223, H2O.1, H2O.1

1 x 6DW: 1-(cyclopropylmethyl)-5-(2-(2,3-dihydro-1H-imidazo[1,2-a]benzimidazol-1-yl)ethoxy)-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one(Non-covalent)

6DW.3: 16 residues within 4Å: Chain A: Y.73, H.74, L.184, D.223, L.224, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.73, A:L.184, A:I.241, A:I.241, A:Y.242, A:F.245, A:P.261, A:E.270, A:V.271, A:F.278 Hydrogen bonds: A:Y.73, A:Y.242, A:Q.275 pi-Stacking: A:F.278

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yoshikawa, M. et al., Design and synthesis of potent and selective pyridazin-4(1H)-one-based PDE10A inhibitors interacting with Tyr683 in the PDE10A selectivity pocket. Bioorg.Med.Chem. (2016)

Release Date

2016-06-29

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence